268 related articles for article (PubMed ID: 17591554)
1. Synthesis and positron emission tomography studies of C-11-labeled isotopomers and metabolites of GTS-21, a partial alpha7 nicotinic cholinergic agonist drug.
Kim SW; Ding YS; Alexoff D; Patel V; Logan J; Lin KS; Shea C; Muench L; Xu Y; Carter P; King P; Constanzo JR; Ciaccio JA; Fowler JS
Nucl Med Biol; 2007 Jul; 34(5):541-51. PubMed ID: 17591554
[TBL] [Abstract][Full Text] [Related]
2. Hydroxy metabolites of the Alzheimer's drug candidate 3-[(2,4-dimethoxy)benzylidene]-anabaseine dihydrochloride (GTS-21): their molecular properties, interactions with brain nicotinic receptors, and brain penetration.
Kem WR; Mahnir VM; Prokai L; Papke RL; Cao X; LeFrancois S; Wildeboer K; Prokai-Tatrai K; Porter-Papke J; Soti F
Mol Pharmacol; 2004 Jan; 65(1):56-67. PubMed ID: 14722237
[TBL] [Abstract][Full Text] [Related]
3. In vivo evaluation of alpha7 nicotinic acetylcholine receptor agonists [11C]A-582941 and [11C]A-844606 in mice and conscious monkeys.
Toyohara J; Ishiwata K; Sakata M; Wu J; Nishiyama S; Tsukada H; Hashimoto K
PLoS One; 2010 Feb; 5(2):e8961. PubMed ID: 20126539
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of new imaging agent for central nicotinic acetylcholine receptor α7 subtype.
Ogawa M; Nishiyama S; Tsukada H; Hatano K; Fuchigami T; Yamaguchi H; Matsushima Y; Ito K; Magata Y
Nucl Med Biol; 2010 Apr; 37(3):347-55. PubMed ID: 20346874
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biodistribution of radiolabeled alpha 7 nicotinic acetylcholine receptor ligands.
Pomper MG; Phillips E; Fan H; McCarthy DJ; Keith RA; Gordon JC; Scheffel U; Dannals RF; Musachio JL
J Nucl Med; 2005 Feb; 46(2):326-34. PubMed ID: 15695794
[TBL] [Abstract][Full Text] [Related]
6. Metabolism and disposition of GTS-21, a novel drug for Alzheimer's disease.
Azuma R; Komuro M; Korsch BH; Andre JC; Onnagawa O; Black SR; Mathews JM
Xenobiotica; 1999 Jul; 29(7):747-62. PubMed ID: 10456692
[TBL] [Abstract][Full Text] [Related]
7. The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21).
Kem WR
Behav Brain Res; 2000 Aug; 113(1-2):169-81. PubMed ID: 10942043
[TBL] [Abstract][Full Text] [Related]
8. Preclinical and the first clinical studies on [11C]CHIBA-1001 for mapping alpha7 nicotinic receptors by positron emission tomography.
Toyohara J; Sakata M; Wu J; Ishikawa M; Oda K; Ishii K; Iyo M; Hashimoto K; Ishiwata K
Ann Nucl Med; 2009 May; 23(3):301-9. PubMed ID: 19337782
[TBL] [Abstract][Full Text] [Related]
9. Evaluation in rats and primates of [11C]-mecamylamine, a potential nicotinic acetylcholine receptor radioligand for positron emission tomography.
Sobrio F; Debruyne D; Dhilly M; Chazalviel L; Camsonne R; Kakiuchi T; Tsukada H; Barré L
Neurochem Int; 2005 May; 46(6):479-88. PubMed ID: 15769550
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and positron emission tomography studies of carbon-11-labeled imatinib (Gleevec).
Kil KE; Ding YS; Lin KS; Alexoff D; Kim SW; Shea C; Xu Y; Muench L; Fowler JS
Nucl Med Biol; 2007 Feb; 34(2):153-63. PubMed ID: 17307123
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors.
Doll F; Dolci L; Valette H; Hinnen F; Vaufrey F; Guenther I; Fuseau C; Coulon C; Bottlaender M; Crouzel C
J Med Chem; 1999 Jun; 42(12):2251-9. PubMed ID: 10377231
[TBL] [Abstract][Full Text] [Related]
12. Derivatives of (-)-7-methyl-2-(5-(pyridinyl)pyridin-3-yl)-7-azabicyclo[2.2.1]heptane are potential ligands for positron emission tomography imaging of extrathalamic nicotinic acetylcholine receptors.
Gao Y; Horti AG; Kuwabara H; Ravert HT; Hilton J; Holt DP; Kumar A; Alexander M; Endres CJ; Wong DF; Dannals RF
J Med Chem; 2007 Aug; 50(16):3814-24. PubMed ID: 17629263
[TBL] [Abstract][Full Text] [Related]
13. Radiosynthesis and in vivo evaluation of two imidazopyridineacetamides, [(11)C]CB184 and [ (11)C]CB190, as a PET tracer for 18 kDa translocator protein: direct comparison with [ (11)C](R)-PK11195.
Hatano K; Sekimata K; Yamada T; Abe J; Ito K; Ogawa M; Magata Y; Toyohara J; Ishiwata K; Biggio G; Serra M; Laquintana V; Denora N; Latrofa A; Trapani G; Liso G; Suzuki H; Sawada M; Nomura M; Toyama H
Ann Nucl Med; 2015 May; 29(4):325-35. PubMed ID: 25616581
[TBL] [Abstract][Full Text] [Related]
14. Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [
Eberl S; Katsifis A; Peyronneau MA; Wen L; Henderson D; Loc'h C; Greguric I; Verschuer J; Pham T; Lam P; Mattner F; Mohamed A; Fulham MJ
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):296-307. PubMed ID: 27699720
[TBL] [Abstract][Full Text] [Related]
15. Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis.
Pavlov VA; Ochani M; Yang LH; Gallowitsch-Puerta M; Ochani K; Lin X; Levi J; Parrish WR; Rosas-Ballina M; Czura CJ; Larosa GJ; Miller EJ; Tracey KJ; Al-Abed Y
Crit Care Med; 2007 Apr; 35(4):1139-44. PubMed ID: 17334244
[TBL] [Abstract][Full Text] [Related]
16. α7 nicotinic acetylcholine receptor agonist GTS-21 attenuates ventilator-induced tumour necrosis factor-α production and lung injury.
Kox M; Pompe JC; Peters E; Vaneker M; van der Laak JW; van der Hoeven JG; Scheffer GJ; Hoedemaekers CW; Pickkers P
Br J Anaesth; 2011 Oct; 107(4):559-66. PubMed ID: 21771746
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vivo evaluation of novel PET radioligands for imaging the endothelin-A receptor.
Mathews WB; Murugesan N; Xia J; Scheffel U; Hilton J; Ravert HT; Dannals RF; Szabo Z
J Nucl Med; 2008 Sep; 49(9):1529-36. PubMed ID: 18703610
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate.
Chattopadhyay S; Xue B; Collins D; Pichika R; Bagnera R; Leslie FM; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
J Nucl Med; 2005 Jan; 46(1):130-40. PubMed ID: 15632043
[TBL] [Abstract][Full Text] [Related]
19. 18F-labeled styrylpyridines as PET agents for amyloid plaque imaging.
Zhang W; Kung MP; Oya S; Hou C; Kung HF
Nucl Med Biol; 2007 Jan; 34(1):89-97. PubMed ID: 17210465
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vivo evaluation of [O-methyl-11C](2R,4R)-4-hydroxy-2-[2-[2-[2-(3-methoxy)phenyl]ethyl]phenoxy]ethyl-1-methylpyrrolidine as a 5-HT2A receptor PET ligand.
Kumar JS; Prabhakaran J; Erlandsson K; Majo VJ; Simpson NR; Pratap M; Van Heertum RL; Mann JJ; Parsey RV
Nucl Med Biol; 2006 May; 33(4):565-74. PubMed ID: 16720250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
